Madrid / San Francisco / Lucknow / Washington / Basel / Waltham / Geneva / Taejon / Boston / Liverpool / Bangalore / New York / Seoul / Cape Town / Melbourne / London / Brussels / /
Company
Humana / Novartis / Rhone-Poulenc Rorer / GlaxoSmithKline / Merck / Sanofi / Parexel International Corp. / Roberts S. A. / J. Pharm / Bristol-Myers Squibb / Bayer / Aventis / United Nations Development Programme/World Bank / Marion / Private Partnerships / NeXstar / Malaria Venture / Proactive / TDR Scientific Working Group / Zentaris AG / Ames / AstraZeneca / /
Continent
Europe / /
Country
Switzerland / South Africa / Australia / Korea / China / India / United States / South Korea / Spain / /
Currency
USD / / /
Event
FDA Phase / Company Expansion / Business Partnership / Person Communication and Meetings / /
Facility
Pharmacy Formulation / S. Capacity building / Walter Reid US Army Institute of Research / University of North Carolina / Walter Reed US Army Institute of Research / R. Building / Central Drug Research Institute / Novartis Institute / Wellesley College / Veterans Administration Medical Center / /
IndustryTerm
pharmaceutical industry / venture capital investment27 / treatment for malaria / combinatorial chemical libraries / chemical infrastructure / pharmaceutical qualities / genomic technologies / pharmaceutical lead optimization / pharmaceutical research / non-proprietary chemical libraries / chemical entities / drug development infrastructure / chemical entity / manufacturing / market-financed innovative products / pharmaceutical needs / Technology transfer / natural products / Short-term solutions / governance systems / chemical leads / pharmaceutical / project management / drug discovery technology / prevention of chronic stage of disease / poor regulatory infrastructure / biopharmaceutical properties / pharmaceutical properties / /
MedicalCondition
trypanosomiasis / neglected disease / target diseases / coma / schistosomiasis / leishmaniasis / tropical/neglected diseases / Chagas disease / early and late stage disease / onchocerciasis / such diseases / cancer / malaria / affordable tuberculosis / diseases / infectious organisms / HIV/AIDS / dengue / present only malaria / infectious disease / tropical disease / TB / several diseases / chronic stage / endemic diseases / African trypanosomiasis / specific diseases / uncomplicated falciparum malaria / competitively selected malaria / communicable diseases / disease / Indian visceral leishmaniasis / neglected diseases / sickness / human malaria / severe malaria / infectious diseases / tropical diseases / visceral leishmaniasis / human African trypanosomiasis / human disease / tuberculosis / /
World Health Organization / FDA GLP / Chemotherapy Portfolio Review Committee / Medecins Sans Frontieres / World Health Organisation / Institute for One World Health / United Nations Development Programme / Texas A&M / Commission on Macroeconomics / Wellesley College / European Union / US Army Institute of Research / Commission on Macroeconomics for Health / National Institute of Health / Food and Drug Administration / University of North Carolina / Yale / Global Alliance for TB Drug Development / Harvard School of Public Health / Gates Foundation / office of Health Economics / Advisory Committee on Health Research / World Bank / Global Alliance for Tuberculosis Drug Development / Federal Government / Novartis Institute for Tropical Diseases in Singapore / Indian Council for Medical Research / Central Drug Research Institute / Tufts Center for the Study of Drug Development / Environmental Protection Agency / /
Person
More / Solomon Nwaka / Robert G. Ridley / Shin Poong / Albert Einstein / S. Campbell / Ridley R. G. Putting / DRUG DISCOVERY / /
Position
industry R&D manager / executive / investigator / driver / development scientist / candidate / /
Product
Primaquine / Pyrazinamide / M-16 / Mefloquine / Isoniazid / dapsone / Investigational New Drug / Amphotericin B / Malarone / Safety / VOLUME / /
ProvinceOrState
Nebraska / Indiana / North Carolina / Massachusetts / /
PublishedMedium
Health Economics / /
Technology
X-ray / high-throughput screening / functional genomics / drug discovery / Chemotherapy / drug discovery technology / genomics / bioinformatics / pharmacokinetics / chemical libraries / drug development / /
PERSPECTIVES SCIENCE & SOCIETY Virtual drug discovery and development for neglected diseases